U.S. News: New insights into fibroids might lead to better treatments
UC researchers reveal ways fibroids respond to strain compared to uterine cells
U.S. News & World Report highlighted the University of Cincinnati's research into new avenues to treat fibroids, a painful condition that affects 8 in 10 women during their lifetimes.
Researchers in UC's College of Medicine and College of Engineering and Applied Science found different signaling pathways being used by the fibroid cells compared to the uterine cells.
“That’s important for identifying therapeutic targets because we want to target the tumor without affecting the surrounding tissue,” said Stacey Schutte, an assistant professor of biomedical engineering in UC’s College of Engineering and Applied Science.
The study was published in the journal F&S Science.
In their study, fibroid cells and uterine cells were grown in the lab on plates with an elastic bottom. Researchers then used a vacuum to pull and stretch the cells, mimicking the uterine environment. They saw differences in the way cells held their shape.
"We found that fibroid cells were more sensitive to strain," said lead author Dr. Rachel Warwar, from the University of Cincinnati's College of Medicine. She said the findings underscore the importance of incorporating mechanical strain, and not just hormones, into the study of fibroid cells.
"The more we are able to mimic the environment of these cells in the uterus, the more we will understand the pathology of these cells and then can work to target anomalous pathways in fibroid cells," Warwar added.
Read the U.S. News & World Report story.
Featured image at top: UC Research Associate Andreja Moset Zupan, left, and Assistant Professor Stacey Schutte study new avenues to treat fibroids in Schutte's biomedical engineering lab. Photo/Andrew Higley/UC Marketing + Brand
UC Research Associate Andreja Moset Zupan, left, and Assistant Professor Stacey Schutte study new avenues to treat fibroids in Schutte's biomedical engineering lab. Photo/Andrew Higley/UC Marketing + Brand
Related Stories
U.S. News: New insights into fibroids might lead to better treatments
January 2, 2024
U.S. News & World Report highlights research collaboration between UC's College of Medicine and the College of Engineering and Applied Science that examined cell signaling by fibroids.
UC examines how painful fibroids grow
December 21, 2023
Insights into how uterine tumors grow could give hope to millions of women who deal with painful fibroids.
Local news highlights opening of UC Bioscience Center
August 17, 2023
Cincinnati news outlets covered the opening of the University of Cincinnati's Bioscience Center, which will collaborate with doctors to create groundbreaking medical technology.
OncLive and Targeted Oncology: Drug yields long-lasting benefits to treat PEComa tumors
March 22, 2024
OncLive and Targeted Oncology covered research presented by the University of Cincinnati's Thomas Herzog that found patients with perivascular epithelioid sarcoma (PEComa) of gynecologic or peritoneal origin experienced rapid, durable responses when treated with the drug nab-sirolimus.
55KRC: UP-NEXT study tests ovarian cancer treatment
April 13, 2023
The University of Cincinnati's Amanda Jackson joined 55KRC's Simply Medicine program to discuss the UP-NEXT ovarian cancer clinical trial.
OncLive: ADCs emerge as exciting addition to ovarian cancer treatment
January 3, 2023
The University of Cincinnati's Caroline Billingsley, MD, was featured in a Q&A article on OncLive discussing the use of antibody-drug conjugates in ovarian cancer treatment.
55KRC: Late-stage cervical cancers on the rise in U.S.
September 12, 2022
The University of Cincinnati's Thomas Herzog, MD, was featured on 55KRC radio's Simply Medicine program to discuss a recent study that found that metastatic, or advance stage, cervical cancer cases are increasing in the United States.
Local 12: UC's Pinder named Cancer Moonshot Scholar
October 23, 2023
The University of Cincinnati Cancer Center's Leeya Pinder joined Local 12's What's Happening in Health to discuss her Cancer Moonshot Scholars research project focused on cervical cancer prevention for women living with HIV in Zambia.
U.S. News & World Report: Ovarian cancer causes, diagnosis and treatments
March 29, 2024
The University of Cincinnati's Amanda Jackson spoke with U.S. News & World Report about ovarian cancer risk factors and prevention.
Alabama.com: How a new self-test for HPV could be a game changer
April 19, 2024
The University of Cincinnati's Leeya Pinder was featured in an Alabama.com/Reckon article about how self-testing for HPV could make preventative care more accessible to those facing the most barriers.